Publikasi Scopus FKUI Tahun 2010 s/d 2020 (data Per 3 Februari 2021)

Wijaya I., Abdullah M.
11142205800;7103393434;
Diagnosis and treatment update: cholangiocarcinoma.
2011
Acta medica Indonesiana
43
3
212
215
6
Department of Internal Medicine. Faculty of Medicine, University of Indonesia, Dr.Cipto Mangunkusumo Hospital, Indonesia
Wijaya, I., Department of Internal Medicine. Faculty of Medicine, University of Indonesia, Dr.Cipto Mangunkusumo Hospital, Indonesia; Abdullah, M.
Cholangiocarcinoma is a rare and very aggressive neoplasm that arises from the biliary epithelium, constitutes approximately 2% of all reported cancer, and accounts for about 3% of all gastrointestinal malignancies. Up to date, there are many modalities to diagnosis and treat with a range of sensitivity and specificity, and also the advantage and disadvantage of its modality. As a physician, we should be able to assess and choose promptly which modality is best for our patient, even for paliative care. Treatment modalities are surgery and non-surgery like adjuvant chemotherapy, radiation, chemoradiation, radiotherapy, TACE, 5-FU chemoinfusion, intralesion PEI, photodynamic therapy, liver transplantation, and paliative therapy. The choice of treatment varies individually. Radical surgery remains the optimal therapy and offering a potential for cure. Overall prognosis in these patients is poor and survival is limited to a few months.
article; bile duct carcinoma; biliary tract tumor; classification; human; prognosis; Biliary Tract Neoplasms; Cholangiocarcinoma; Humans; Prognosis
01259326
21979289
Article
Q3

Unit Riset FKUI/Medical Research Unit
Gedung IMERI Tower Riset lt. 9, Jl. Salemba Raya No. 6, Jakarta Pusat, 10430
Telp. : +62 21 29189160 (ext. 201912)
E-mail : manajer.riset.fkui1@gmail.com

© {2022} Riset & Pengabdian Masyarakat. All Rights Reserved.